Deep Track Capital’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-609,900
| Closed | -$3.4M | – | 71 |
|
2024
Q4 | $3.4M | Sell |
609,900
-3,486,552
| -85% | -$19.4M | 0.13% | 59 |
|
2024
Q3 | $44.3M | Buy |
4,096,452
+35,051
| +0.9% | +$379K | 1.4% | 25 |
|
2024
Q2 | $85.2M | Buy |
4,061,401
+1,026,948
| +34% | +$21.6M | 2.54% | 15 |
|
2024
Q1 | $96.7M | Buy |
3,034,453
+750,081
| +33% | +$23.9M | 2.77% | 16 |
|
2023
Q4 | $46.3M | Sell |
2,284,372
-493,735
| -18% | -$10M | 1.55% | 25 |
|
2023
Q3 | $35.4M | Hold |
2,778,107
| – | – | 1.37% | 26 |
|
2023
Q2 | $50.2M | Buy |
2,778,107
+500,000
| +22% | +$9.04M | 2.32% | 16 |
|
2023
Q1 | $39.2M | Sell |
2,278,107
-378,794
| -14% | -$6.51M | 1.61% | 22 |
|
2022
Q4 | $59M | Sell |
2,656,901
-539,741
| -17% | -$12M | 2.48% | 14 |
|
2022
Q3 | $25.7M | Buy |
3,196,642
+56,642
| +2% | +$455K | 1.18% | 32 |
|
2022
Q2 | $21.9M | Buy |
3,140,000
+691,800
| +28% | +$4.83M | 1.44% | 24 |
|
2022
Q1 | $37M | Buy |
2,448,200
+548,200
| +29% | +$8.29M | 2.37% | 16 |
|
2021
Q4 | $41.7M | Buy |
+1,900,000
| New | +$41.7M | 2.94% | 11 |
|